Member Info for gixer

Not sure what 4 tests you refer to.

colbaltblue, young enough to wait until 1 January 2023 when By-Health will be able to distribute Fruitflow as an ingredient to other businesses and manufacture, market, and sell Fruitflow based functional food and dietary supplement finished products in Mainland China, Hong Kong, Macau, Taiwan and Australia.
How soon that will start to happen in 2023, who knows, but willing to wait.

Exactly DP64,
We have gone from.........
Launch a few Fruitflow products to
Get Blue Cap, to
Changing the SAMRs permitted health claim register, and now
Drug research and development projects.
So far with a significant investment at By-Health's expense.

Yes it would have been nice to see some revenue from By-Health along the way but it will come.

Cardio Fortis
From Hungary I think
https://multivitaminbolt.com/Cardio-Fortis-30-db-kapszula-Fruitflow-kivonattal-resveratrol-rutin

Barbershop,
Funding for the pilot study was provided by DSM Nutritional Products and the Preprint of the study seems to indicate that they (DSM) could be looking at personalizing the dosage of Fruitflow.
"Despite the limitations of this study, the data generated suggests that that a larger study which addresses
the bias contained in this pilot study should be undertaken to confirm that the efficacious dose range for
Fruitflow® is between 75mg and 300mg; that personalizing the dosage of Fruitflow® could be an option
to deliver optimal effects, given the observable heterogeneity of the response between individuals; and
besides, that further investigation of TGC as a surrogate marker for monitoring the effects of the
intervention on platelet function is warranted."
https://assets.researchsquare.com/files/rs-479553/v1/b85d9d3c-0329-4a9a-a980-1fff8fbbd814.pdf?c=1631883204

The above would then lead you to the next question (well it did to me), and that is. Why?

The only answer that I can think of is that DSM have relatively recently invested $100 Million in Health tech company Hologram Sciences to launch personalized health & nutrition innovations.
"Backed by DSM, Hologram seeks to disrupt nutrition marketplace by offering consumer-facing personalized solutions"
https://www.dsm.com/human-nutrition/en/talking-nutrition/press-releases/2021-04-05-health-tech-company-hologram-sciences-launches-personalized-health-and-nutrition-Innovation-with-us-100-million-backing.html

https://www.nutraingredients-usa.com/Article/2021/04/08/Royal-DSM-launches-personalized-health-tech-company

https://hologramsciences.com/

BWTFDIK :-)

Our latest paper "Evaluation of the equivalence of different intakes of Fruitflow in affecting platelet aggregation and thrombin generation capacity in a randomized, double-blinded pilot study in male subjects" by Das, R, Datta, T., Biswas, D., Duss, R., O'Kennedy, N., & Duttaroy, A.K. is now accepted for publication in BMC Nutrition Journal.
https://www.facebook.com/asimkduttaroy/posts/296545209138158

If thats what you think then fine but the trade @09:51 this morning is most likely a buy at under the mid price and as far as I saw today the spread never changed.

Another shown up after hours.

" I bet you wish you'd never set eyes on Provexis as an "investment""
Wrong. If I sold today I would have a good return on my investment thank you.
So no its not been "a complete waste of time"

"LOL! Do you think it will be better"
I think its better already.

"You are so deluded"
No.

Just for clarity.
DSM have not washed there hands of Fruitflow.
"The Company and DSM have started and are currently engaged in constructive negotiations working towards a new agreement."
and
" a significant investment in eight separate Fruitflow studies has been undertaken at By-Health's expense."
https://www.lse.co.uk/rns/PXS/by-health-fruitflow-agreement-and-support-in-rd-ls3bxdcrszm4v6m.html

Another late reported trade that's shown as a sell but looks like a buy.

"large companies?"
We have large, very large.
"The market value of BY-Health ranks first in the industry"
"On December 15, 2010, BY-HEALTH (300146.SZ) was listed on the GEM and became the first Chinese A-share "Dietary Nutrition Supplement (VDS) Share". The company's market value on that day recorded RMB 8.026 billion.
Today, ten years later, as of June 16, 2021, By-Health's market value has reached 60.327 billion yuan, surpassing Herbalife in one fell swoop and becoming the world's most valuable VDS company."
https://new.qq.com/omn/20210621/20210621A02FIT00.html

Although I doubt DSM had much to do with it.

As its 3,000,000 from yesterday I would say its definitely a buy.

Since the resident Troll got the whole thread removed again.........

Lu Xiong
Licensed pharmacist (Edited 5 hours ago)
Talking platelets and recommending Fruitflow in answer to a question

Water-soluble tomato concentrate can control platelet aggregation in many ways. On the one hand, it can inhibit protein disulfide isomerase and reduce platelet activation [3]; on the other hand, it can inhibit the activation of integrin aIIbß3 and the expression of CD62P protein on the platelet surface, and reduce platelet aggregation [4]. At the same time, it also has a significant inhibitory effect on platelet aggregation mediated by ADP, collagen, thrombin, and arachidonic acid [4]. In addition, in a number of clinical studies currently conducted, it has found no side effects and can be used for a long time .Therefore, products containing these extracts can also be taken to protect the health of platelets and avoid excessive accumulation of platelets in blood vessels. For example, Xinluoxin, its main ingredient is water-soluble tomato concentrate."
https://www.zhihu.com/question/496136212/answer/2211446186

"What is the mechanism of action of water-soluble tomato concentrate (Fruitflow)?"
2021-11-10

"In recent years, the water-soluble tomato concentrate (Fruitflow) that has attracted much attention in recent years is an effective ingredient for inhibiting platelet aggregation. In the third China Health Food Conference in 2019, a company revealed that it is developing a new water-soluble tomato concentrate. Water-soluble tomato concentrate can effectively reduce the platelet aggregation rate, inhibit the activation of platelet aIIbß3, inhibit FeCl 3 induced mesenteric artery thrombosis, and down-regulate the phosphorylation level of platelet Akt, Erk1/2 and JNK protein without prolonging bleeding time."
https://www.163.com/dy/article/GOEHIGKN0552M4JW.html

DP64, The board I was referring to was ADVFN share chat and to be honest I don't post on there very often.

I put an email address on the other board that you can contact me on and send your number.

Killed any buying this morning with a spread like that.

Long term strategic co-operation framework agreement aside.
This is probably the best publicity Provexis and Fruitflow have had in China.

https://www.baidu.com/s?wd=%22%E6%B1%A4%E8%87%A3%E5%80%8D%E5%81%A5%22%20%22fruitflow%22%20%22%E8%BD%BB%E7%BB%9C%E7%B4%A0%22&pn=0&oq=%22%E6%B1%A4%E8%87%A3%E5%80%8D%E5%81%A5%22%20%22fruitflow%22%20%22%E8%BD%BB%E7%BB%9C%E7%B4%A0%22&ie=utf-8&rsv_pq=a2f20e590007c4d8&rsv_t=482fJxzdEcgY4%2BOKpW4BGUnYH8LGZNISDZyAbE3RvAUuTQBc9SlH98I9AwU&gpc=stf%3D1633515099%2C1636193499%7Cstftype%3D1&tfflag=1&bs=%22%E6%B1%A4%E8%87%A3%E5%80%8D%E5%81%A5%22%20%22fruitflow%22%20%22%E8%BD%BB%E7%BB%9C%E7%B4%A0%22&rsv_jmp=fail

https://www.google.co.uk/search?q=%22%E6%B1%A4%E8%87%A3%E5%80%8D%E5%81%A5%22+%22fruitflow%22&tbas=0&tbs=qdr:w&sxsrf=AOaemvI5xxZiZVCF8WS0cj0QGJSj5KUqmg:1636193421492&ei=jVSGYe24HdXD8gLM1LOQCw&start=0&sa=N&ved=2ahUKEwits6-9v4P0AhXVoVwKHUzqDLI4HhDy0wN6BAgBEDs&biw=1366&bih=625&dpr=1

"Focusing on consumer health, the company has continued to try to expand into new business
segments. In 2020, the company has tried to deploy over-the-counter drugs (OTC) business and
functional food business which are still in the incubation period. In the massive health industry
ecosystem centered on VDS, extending upward to OTC, and downward to functional foods, the
company continued to build and enrich the brand matrix in different business segments, and forming a
good complementarity among brand positioning, consumer groups and needs, and constantly
consolidated brand power to create value for consumers' health."

"17. Establishment of Guangzhou Hurui Pharmaceutical Technology Development Co,. Ltd
On August 20, 2020,Guangzhou Hurui Pharmaceutical Investment Co,. Ltdset up a new wholly-owned subsidiary, Guangzhou Hurui Pharmaceutical Technology Development Co,. Ltd, with a registered capital of RMB 10 million and
the executive director of LIN Zhicheng. This company is mainly used for holding OTC approval and outsourced
processing"

https://upload-yyj.by-health.com/upload/files/0324160545898_2020%20Annual%20Report%20(Compact%20Edition).pdf